Dr. Rossella Canese has long-term experience in quantitative magnetic resonance imaging and spectroscopy in preclinical studies applied to oncology, neuroscience and metabolic disease. Since more than 30 years she has been carrying out research aimed at identifying new diagnostic and prognostic indicators and characterizing pharmacological endpoints in several diseases using magnetic resonance imaging (MRI) and spectroscopy (MRS) in vivo techniques, as a basis for the possible realization of innovative pathways of translational medicine. Her major research interests include metabolic and functional studies in animal models, molecular imaging applications (quantitative MRI, functional/connectivity MRI, in vivo quantitative MRS), effects of treatment. She has been head of research of MRI unit in several nationaland European projects. Official H index = 25 (Research gate) or 23 (Web of Science) Scopus ID : 6602598715 Researcher ID : B-3969-2017 ORCID ID : 0000-0001-9093-6803 She is author of more than 67 publications (2262 cit.) in peer-reviewed international journals (30 of them with the name in prevalent position) and she was invited to give lectures in national and international conferences. She is member of the faculty of the PhD in Biophysics (Sapienza Univ., Rome). She is member of ISMRM, AIRMM, GIDRM, CTLS scientific society. She is member of the Editorial Board of Frontiers in Oncology and reviewer for journals and proposals from EU.